AmeriPath launches $125 million term loan

By Sara Rosenberg

New York, Feb. 3 - AmeriPath Inc. launched a $125 million term loan on Tuesday, according to a market source. Credit Suisse First Boston and Deutsche Bank are the lead banks on the deal.

The term loan is priced with an interest rate of Libor plus 275 basis points.

Proceeds from the tranche, which is being obtained under the company's existing credit facility, will be used in combination with about $10 million of cash on hand and proceeds from a proposed $75 million senior subordinated notes offering to repay the existing term loan and pay related fees and expenses, according to a company news release.

AmeriPath is a Riviera Beach, Fla., provider of cancer diagnostics, genomics and related information services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.